Wolverine Trading, LLC Humanigen, Inc Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.33 $40,092 - $75,857	-22,780 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.81 - $3.97 $29,959 - $65,711	-16,552 Reduced 42.08%	22,780 $71,000
Q4 2021 Feb 14, 2022	BUY	$3.66 - $8.22 $92,824 - $208,475	25,362 Added 181.55%	39,332 $154,000
Q3 2021 Nov 12, 2021	SELL	$5.93 - $17.83 $39,855 - $119,835	-6,721 Reduced 32.48%	13,970 $85,000
Q2 2021 Aug 06, 2021	BUY	$13.54 - $22.74 $280,156 - $470,513	20,691 New	20,691 $356,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.